Information contained on this page is provided by an independent third-party content provider. WorldNow and this Station make no warranties or representations in connection therewith. If you have any questions or comments about this page please contact firstname.lastname@example.org.
SOURCE Americord Registry
Americord's Significant Investment in Brooklyn Will Create New Jobs in New York
NEW YORK, June 11, 2014 /PRNewswire/ -- Americord announced today that it will expand its presence in New York as a result of START-UP NY, an initiative that creates tax-free areas across New York State. Under the program, Americord will invest more than $402,000 toward a new research and development laboratory and spur the creation of new jobs.
"We are thrilled to be among the first companies to take part in Governor Andrew Cuomo's START-UP NY program," said Americord CEO Martin Smithmyer. "SUNY Downstate Medical Center in Brooklyn is a leader in the biotech industry, so this is an exceptional opportunity for us to develop innovative stem cell preservation technologies at the lowest possible cost while maintaining the highest standards." In addition to research and development, Americord also plans to locate certain operational activities at SUNY Downstate Brooklyn.
Americord's track record of more than 2,200% growth since 2011 indicates that it is the fastest growing cord blood bank in the United States.
Americord is a leader in the advancement of umbilical cord blood, cord tissue and placenta tissue banking. Americord collects, processes, and stores newborn stem cells from umbilical cord blood for future medical or therapeutic use, including the treatment of more than 80 blood diseases such as sickle cell anemia and leukemia. Founded in 2008, Americord is registered with the FDA and operates in all 50 states. The company's laboratory is CLIA Certified, accredited by the AABB and complies with all federal and state guidelines and applicable licenses. Americord is headquartered in New York, NY. You may visit Americord's website at cordadvantage.com for more information. You may also find Americord on Facebook and follow the company on Twitter.
©2012 PR Newswire. All Rights Reserved.